Furthermore, post-mortem analysis of prefrontal cortex samples revealed no differences in the expression levels of ADORA2A gene or protein between schizophrenia patients and healthy controls, nor between drug-free and antipsychotic-treated patients (Urigüen et al., 2009). Here, ADORA2A is linked to schizophrenia.